Suat Nail Ömeroğlu

Suat Nail Ömeroğlu

Auto-generated profile, based on publicly available information

Suat Nail Ömeroğlu

Cerrahpasa Medical Faculty, Department of Cardiovascular Surgery, Istanbul University-Cerrahpasa, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2005 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
SOSuat Nail Omeroglu
Suat Nail Omeroglu
HAHasan Ardal
Hasan Ardal
HEHasan Basri Erdogan
Hasan Basri Erdogan
EEErcan Eren
Ercan Eren
VEVedat Erentug
Vedat Erentug
CYCevat Yakut
Cevat Yakut
We studied patients with coronary artery disease (CAD) and complete atrioventricular (AV) block of acute onset that were treated with coronary artery bypass grafting (CABG) to see whether revascularization can restore the sinus rhythm. CABG was performed on eight patients with newly developed complete AV block and severe CAD. The distribution of coronary artery lesions showed a type IV pattern in six patients and a type II pattern in two patients. Complete revascularization was performed in six patients. Left anterior descending artery was revascularized in all eight patients. The patients were followed-up after operation for approximately 10 days before the implantation of a permanent pacemaker to see if they recover from AV block. The mean interval from development of complete AV block to operation was 3.63 +/- 1.3 days. There was no operative and/or early mortality. None of the patients recovered from complete AV block after coronary revascularization. Early morbidity was not detected. The mean hospital stay (12.75 +/- 1.49 days) and intensive care unit stay (30.25 +/- 19.39 hours) were relatively long because of the delay in permanent pacemaker implantation. All patients were asymptomatic at the end of their follow-up period (23.38 +/- 18.41 months). Preoperatively developed complete AV block did not adversely affect the operative and early postoperative outcome of CABG operations. Recovery from complete AV block cannot be achieved by coronary revascularization performed 3.63 +/- 1.3 days after the onset of complete AV block.

1 January 2004
Verified
Journal Article
Closed access
SOSuat Nail Omeroglu
Suat Nail Omeroglu
AOAtilla Omeroglu
Atilla Omeroglu
HAHasan Ardal
Hasan Ardal
AEAtakan Erkilinc
Atakan Erkilinc
EBEbru Bal
Ebru Bal
CYCevat Yakut
Cevat Yakut

10 June 2025 in Cardiovascular Toxicology
Verified
Journal Article
Open access
PDF file
IŞİlKnur Şahin
İlKnur Şahin
SBSEBNEM BATUR
SEBNEM BATUR
AÜAhmet Üstündağ
Ahmet Üstündağ
BABerk Arapi
Berk Arapi
CUCigdem Tel Ustunisik
Cigdem Tel Ustunisik
OBOzan Onur Balkanay
Ozan Onur Balkanay
It is known that COVID-19 patients may experience endothelial cell inflammation, apoptosis, dysfunction, and systemic coagulation disorders. In CABG operations, graft patency plays a crucial role in survival and morbidity. Thrombosis and endothelial cell inflammation in grafts can pose challenges for CABG candidates with a history of COVID-19. This study aimed to evaluate the vasculitic effects of a history of COVID-19 among CABG patients. A total of 94 consecutive patients, including 34 with a history of COVID-19 and 60 without, who were scheduled for CABG at our clinic, were included in the study after informed consent was obtained. Patients with a history of COVID-19 underwent surgery at least 4 weeks after the recovery of infection. Thromboembolic events were monitored throughout the hospital stay, and vascular grafts obtained during surgery were pathologically evaluated for signs of vasculitis and inflammation. All COVID-19 (n = 34) cases were mild. Statistical analysis revealed no significant difference between the groups regarding vein thrombosis/thrombophlebitis (p = 0.626). Additionally, pathological evaluation showed no signs of vasculitis or inflammation. There were also no significant differences in postoperative mortality and morbidity between the two groups (p > 0.05). Based on our findings, undergoing CABG surgery after a four-week recovery period appears to be safe for patients with a history of mild COVID-19, at least in terms of early postoperative vascular outcomes.

1 January 2005
Verified
Journal Article
Closed access
SOSuat Nail Omeroglu
Suat Nail Omeroglu
DMDenyan Mansuroglu
Denyan Mansuroglu
DGDeniz Goksedef
Deniz Goksedef
YCYakut Cevat
Yakut Cevat

1 January 2004
Verified
Journal Article
Closed access
SOSuat Nail Omeroglu
Suat Nail Omeroglu
KKKaan Kirali
Kaan Kirali
DMDenyan Mansuroglu
Denyan Mansuroglu
DGDeniz Goksedef
Deniz Goksedef
MBMehmet Balkanay
Mehmet Balkanay
CYCevat Yakut
Cevat Yakut

1 September 2004 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
SÖSuat N Ömeroğlu
Suat N Ömeroğlu
HEHasan B Erdoğan
Hasan B Erdoğan
KKKaan Kirali
Kaan Kirali
AÖAtilla Ömeroğlu
Atilla Ömeroğlu
MTMehmet E Toker
Mehmet E Toker
CYCevat Yakut
Cevat Yakut
Combined coronary bypass and lung surgery was performed in 3 patients. Through a median sternotomy or a left thoracotomy, bypass grafting was performed on beating heart or under cardiopulmonary bypass, followed by the lung operation. The lung lesion was diagnosed as carcinoma in 2 patients and hydatid cyst in 1 patient. With few exceptions, beating heart coronary bypass through a median sternotomy can be performed in a combined operation.